Urology

Latest Ask the Experts

Biomarker Assays for Prostate Cancer Management

Should biomarker assays be an integral part of prostate cancer patient care?

Urology News

Latest Urology News

Kidney Cancer Partial Nephrectomy for Small Renal Tumors Offers Survival Edge

Partial Nephrectomy for Small Renal Tumors Offers Survival Edge

Partial vs radical nephrectomy is associated with an overall survival advantage among patients with RCC tumors 4 cm or smaller and many patients with larger tumors.

Prostate Cancer High Cholesterol Ups Risk of Aggressive Prostate Cancer

High Cholesterol Ups Risk of Aggressive Prostate Cancer

Men in the highest vs lowest tertile of total cholesterol had a 42% increased risk of Gleason 8-10 prostate cancer, Finnish study finds.

Prostate Cancer Study Zeroes in on Cause of Castration-Resistant Prostate Cancer

Study Zeroes in on Cause of Castration-Resistant Prostate Cancer

Some prostate cancer cells lack androgen receptor, and they proliferate faster than those that express androgen receptor under androgen-deficient conditions.

Overactive Bladder (OAB) Interstitial Cystitis/Bladder Pain Syndrome Linked to EBV

Interstitial Cystitis/Bladder Pain Syndrome Linked to EBV

Epstein-Barr virus infection found much more frequently in patients with vs without IC/BPS and Hunner lesions or controls with stress urinary incontinence.

Kidney Cancer NLR Predicts Survival After Cytoreductive Nephrectomy+Thrombectomy

NLR Predicts Survival After Cytoreductive Nephrectomy+Thrombectomy

A neutrophil-lymphocyte ratio below 4 is associated with significantly longer survival among patients with non-poor-risk metastatic renal cell carcinoma.

Prostate Cancer Annual PSA Screening Best for Reducing Prostate Cancer Deaths

Annual PSA Screening Best for Reducing Prostate Cancer Deaths

A study of 400,887 men in an integrated health system, the first to evaluate various PSA screening intervals and age groups, concluded that yearly screening is the interval of choice.

Prostate Cancer Apalutamide Preserves HRQoL in Nonmetastatic CRPC

Apalutamide Preserves HRQoL in Nonmetastatic CRPC

New analysis of the SPARTAN trial shows that apalutamide maintains health-related quality of life while lowering the risk of metastasis.

Prostate Cancer Prostate Cancer Radiotherapy Effective Long-Term

Prostate Cancer Radiotherapy Effective Long-Term

Australian study shows 8-year overall survival and biochemical relapse-free rates of 78.4% and 68.1%, respectively.

Prostate Cancer Prostate Cancer ADT Linked to Higher Risk of Liver Diseases

Prostate Cancer ADT Linked to Higher Risk of Liver Diseases

Men who received androgen deprivation therapy for prostate cancer were 54% more likely to be diagnosed with non-alcoholic fatty liver disease than those who did not, a study found.

Kidney Cancer Diabetes Population Has Higher Incidences of Bladder, Kidney Cancer

Diabetes Population Has Higher Incidences of Bladder, Kidney Cancer

Finnish study of individuals with type 2 diabetes reveals a 17% and 42% higher incidence of bladder and kidney cancer, respectively, compared with the general population.

Bladder Cancer Neoadjuvant Dose-Dense MVAC May Improve Post-Cystectomy Outcomes

Neoadjuvant Dose-Dense MVAC May Improve Post-Cystectomy Outcomes

Higher rates of complete response observed in MIBC patients who received a dose-dense combination of methotrexate, vinblastine, doxorubicin, and cisplatin rather than the standard gemcitabine plus cisplatin or carboplatin.

Kidney Cancer High BMI at Start of Advanced RCC Systemic Therapy Ups Survival Odds

High BMI at Start of Advanced RCC Systemic Therapy Ups Survival Odds

In a German study of patients starting first-line systemic therapy for advanced renal cell carcinoma, patients with a low BMI were twice as likely to die as those with a high BMI.

Kidney Stones ESRD Risk Higher In Recurrent Stone Formers

ESRD Risk Higher In Recurrent Stone Formers

Recurrent kidney stone formers are at higher risk of end-stage renal disease than patients who form incident symptomatic stones, study finds.

Prostate Cancer Prostate Cancer AS Loss to Follow-Up Risk at 2 Years Estimated at 10%

Prostate Cancer AS Loss to Follow-Up Risk at 2 Years Estimated at 10%

The risk being lost to follow-up while on active surveillance for prostate cancer is higher among blacks than whites, according to a study.

Benign Prostatic Hyperplasia (BPH) Male Bladder Bacteria, LUTS Severity Linked

Male Bladder Bacteria, LUTS Severity Linked

Lower urinary tract symptom severity in men is associated with detectable bacteria in urine obtained via catheter, new study suggests.

Prostate Cancer LDR Brachytherapy Beneficial In High-Risk Prostate Cancer

LDR Brachytherapy Beneficial In High-Risk Prostate Cancer

Low-dose-rate brachytherapy is associated with excellent long-term biochemical control and survival, new study finds.

Prostate Cancer Prostate Cancer Risk Lower In Men in Physically Demanding Jobs

Prostate Cancer Risk Lower In Men in Physically Demanding Jobs

Even low cumulative exposure to physical strain at work is associated with a decreased risk of prostate cancer, study finds.

Prostate Cancer Prostate MRI Use Ups Odds of Prostate Cancer Observation

Prostate MRI Use Ups Odds of Prostate Cancer Observation

In a study, men with low-risk prostate cancer were nearly 2-fold more likely to be managed with observation if they had a prostate MRI during the diagnostic work-up.

Kidney Cancer New Study Supports Recent AUA Guidelines for Small Renal Masses

New Study Supports Recent AUA Guidelines for Small Renal Masses

Prospective study at Johns Hopkins shows excellent oncologic outcomes and preserved mental quality of life for all patients regardless of management strategy, with worse renal function after radical nephrectomy.

Kidney Stones Urinary Stones, Asthma Linked in Adults

Urinary Stones, Asthma Linked in Adults

Urinary stone formation in adults increases the odds of asthma by 26%, according to a study.